Goldman thinks the market is underestimating the odds of a faster-than-expected coronavirus vaccine
August 06, 2020 at 06:48 AM EDT
Markets underappreciate the odds of an early Covid-19 vaccine and the chances of an FDA approval by the end of November, Goldman Sachs says.
